Close

Analyst Ratings for Pluristem Therapeutics (PSTI)

PSTI Rating Summary

  |   Expand Research on PSTI
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 7 / 10   Percentile Rank: 75%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/13/2022 Dawson James Jason Kolbert Downgrade Neutral
(Buy)
N/A
(N/A)
1.19
(1.00)
-15.97% Details
12/10/2020 Jefferies Chris Howerton Downgrade Hold
(Buy)
N/A
(6.00)
7.00
(1.00)
-85.71% Details